About
The Company
Our Heritage
Mission & Vision
Expertise
Products
Pharma
Investor relations
Financial Information
Annual Financials
FY18
FY19
FY20
FY21
Quarterly results 2021-22
Financial Results Q1(April- June)
Financial Results Q2(July- Sep)
Financial results Q3 (Oct- Dec)
Financial results Q4 (Jan- Mar)
Investor Presentation
Result Presentation Q1
Result Presentation Q2
Result Presentation Q3
Result Presentation Q4
Quarterly results press release
Earnings Call Transcript
Audio Transcript
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Corporate Governance
Independent Directors
Audit Committee Charter
CSR Committee Charter
Stakeholder Relationship Committee Charter
Nomination and Remuneration Committee Charter
Terms and Conditions for appointment of Independent Director
Management Team Information
Code of Conduct
Policies
Investor information
Company Fact sheet
Shareholding Pattern
Stock Price
Corporate Announcements
Notice of Board Meeting
Invites and Others
Stock Exchange Communication
Certificate under Reg 74(5)
Monitoring Agency
Statement of Deviation
Investor Contact
Compliance Officer
Investor Relations
Registrar
CSR
Career
Contact
Search
expertise1
Prev
Next
Privacy Preference Center
Privacy Preferences
